InvestorsPrism
  • Home
  • Indexes
    • All Indexes
    • Cannabis
    • EV
    • Gene Therapy
    • MedDevices
    • MedDiagnostics
    • Solar
    • Uranium
    • Vaccines & Cell Therapy
    • Web 3.0
  • Companies
  • Trending News
    • Latest
    • Markets
    • Finance
    • Economy
    • Technology
    • Earnings
    • Healthcare
    • Prism Daily
  • Equity Research
    • Login
    • Register
    • User Profile
    • Log Out
  • Home
  • Indexes
    • All Indexes
    • Cannabis
    • EV
    • Gene Therapy
    • MedDevices
    • MedDiagnostics
    • Solar
    • Uranium
    • Vaccines & Cell Therapy
    • Web 3.0
  • Companies
  • Trending News
    • Latest
    • Markets
    • Finance
    • Economy
    • Technology
    • Earnings
    • Healthcare
    • Prism Daily
  • Equity Research
    • Login
    • Register
    • User Profile
    • Log Out

Home Features

Category: Features

March 14 at 2:04 pm

SuperCom (NASDAQ: SPCB) Revolutionizing the Criminal Justice Industry

SuperCom Ltd. (SPCB) is a global provider of secured solutions for the e-Government, IoT, and Cybersecurity sectors. SuperCom presents an impressive group of experts in… [Read More]
March 01 at 1:27 pm

A Pivotal Year Ahead for Quoin Pharmaceuticals

Company celebrates key milestones and charts path from clinical-stage to commercial. Since commencing trading on Nasdaq in October 2021, Quoin Pharmaceuticals ( Nasdaq: QNRX )… [Read More]
February 17 at 10:00 am

2023 Watchlist: Five Potentially Life-Changing Clinical Trials in Skin Disease

The skin is the body’s largest organ, a barrier protecting us from infectious agents and allergens and preventing water loss. Its healthy functioning is critical… [Read More]
January 10 at 8:45 am

High Margins and Low Capital Costs A Winning Combination for Verde Bio

Mineral rights acquisitions companies benefit directly from increasing commodity prices Oil and gas stocks have long been popular with income-focused investors. When commodity prices are… [Read More]
December 21 at 8:18 pm

Bionik Eyes $4.9 Billion Global Neurorehabilitation Devices Market with New Strategic Direction

Robotics and neurological recovery solutions company Bionik Laboratories (OTCPINK: BKNL), has unveiled a new strategic approach to rehabilitating stroke survivors and others with functional and mobility… [Read More]
November 21 at 3:00 pm

Lexaria Bioscience Turns Focus to Dementia and Diabetes with New Studies

Lexaria Bioscience (Nasdaq): LEXX is investigating the potential therapeutic utility of its proprietary DehydraTECHTM-CBD against dementia and diabetes, two of the world’s biggest public health crises…. [Read More]
electronic blood pressure meter and red heart
September 21 at 9:52 am

Lexaria Bioscience: Taking Aim at the $28 Billion Hypertension Market; Human Clinical Study Yields “Remarkable” Results

Lexaria Bioscience (Nasdaq: LEXX) (Nasdaq: LEXXW) is targeting the $28 billion hypertension drug market with its innovative drug delivery platform. Its proprietary therapeutic, DehydraTECH-CBD, offers… [Read More]
July 01 at 8:14 am

Oxford BioDynamics: A Winning Trifecta of Technology, Story and Strong Management

Biotechnology company, Oxford BioDynamics (AIM:OBD), is poised for successful commercialization of its precision medicine tests for oncology. Any seasoned investor will tell you that investing… [Read More]
InvestorsPrism

Copyright © 2023 Investors Prism
All rights reserved

Company

  • About Us
  • Contact Us
  • Privacy Policy
  • Disclaimer

News

  • Latest
  • Markets
  • Finance
  • Economy
  • Technology
  • Earnings
  • Healthcare
  • Prism Daily

Indexes

  • Cannabis
  • EV
  • Gene Therapy
  • MedDevices
  • MedDiagnostics
  • Solar
  • Uranium
  • Vaccines & Cell Therapy
  • Web 3.0